We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+2.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$8.8B
AUM Growth
+$346M
(+4.1%)
Cap. Flow
+$350M
Cap. Flow
% of AUM
3.97%
Top 10 Holdings %
Top 10 Hldgs %
18.46%
Holding
1,111
New
53
Increased
455
Reduced
293
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$77.4M |
| 2 |
AT&T
T
|
+$35.6M |
| 3 |
Deutsche Bank
DB
|
+$33.1M |
| 4 |
S&P Global
SPGI
|
+$25M |
| 5 |
Texas Instruments
TXN
|
+$24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$37.1M |
| 2 |
HCA Healthcare
HCA
|
+$24.6M |
| 3 |
American Water Works
AWK
|
+$23.9M |
| 4 |
UBS Group
UBS
|
+$18.4M |
| 5 |
Manulife Financial
MFC
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.43% |
| 2 | Financials | 14.33% |
| 3 | Communication Services | 12.73% |
| 4 | Technology | 11.92% |
| 5 | Consumer Staples | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Domino's
DPZ
$11.6B
| $382K | ﹤0.01% |
2,988
+1,200
| +67% | +$153K |
|
727
Liberty Latin America Class A
LILA
$1.67B
| $382K | ﹤0.01% |
+18,384
| New | +$434K |
|
728
Regions Financial
RF
$26.8B
| $382K | ﹤0.01% |
45,318
-17,295
| -28% | -$157K |
|
|
IPXL
729
DELISTED
Impax Laboratories, Inc.
IPXL
| $382K | ﹤0.01% |
13,100
-23,700
| -64% | -$772K |
|
|
ILG
730
DELISTED
ILG, Inc Common Stock
ILG
| $381K | ﹤0.01% |
+24,725
| New | +$353K |
|
731
Federal Realty Investment Trust
FRT
$10.3B
| $380K | ﹤0.01% |
2,322
| – | – |
|
|
HBI
732
DELISTED
Hanesbrands
HBI
| $380K | ﹤0.01% |
14,852
| – | – |
|
|
RHT
733
DELISTED
Red Hat Inc
RHT
| $379K | ﹤0.01% |
5,192
| – | – |
|
|
SGYP
734
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $378K | ﹤0.01% |
101,000
+37,500
| +59% | +$127K |
|
735
Coherus Oncology
CHRS
$196M
| $376K | ﹤0.01% |
22,400
+5,700
| +34% | +$107K |
|
736
XBiotech
XBIT
$69.2M
| $376K | ﹤0.01% |
18,000
+4,000
| +29% | +$57.7K |
|
737
Lennar Class A
LEN
$21.2B
| $372K | ﹤0.01% |
8,520
| – | – |
|
738
Deckers Outdoor
DECK
$13.3B
| $367K | ﹤0.01% |
38,604
-5,640
| -13% | -$52.1K |
|
739
Idexx Laboratories
IDXX
$46.2B
| $366K | ﹤0.01% |
+4,000
| New | +$344K |
|
740
Qorvo
QRVO
$8.74B
| $366K | ﹤0.01% |
6,700
+2,224
| +50% | +$111K |
|
741
Atara Biotherapeutics
ATRA
$76.1M
| $365K | ﹤0.01% |
648
+124
| +24% | +$59.5K |
|
742
Travere Therapeutics
TVTX
$5.78B
| $364K | ﹤0.01% |
20,300
+4,700
| +30% | +$76.1K |
|
|
SCLN
743
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $364K | ﹤0.01% |
27,600
+5,100
| +23% | +$66.8K |
|
744
Principal Financial Group
PFG
$24.3B
| $361K | ﹤0.01% |
8,906
| – | – |
|
745
Cincinnati Financial
CINF
$27.1B
| $360K | ﹤0.01% |
4,862
-2,000
| -29% | -$136K |
|
|
DBVT
746
DBV Technologies
DBVT
$847M
| $360K | ﹤0.01% |
1,110
+120
| +12% | +$38.9K |
|
|
ICPT
747
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $358K | ﹤0.01% |
2,390
-8,080
| -77% | -$1.18M |
|
|
FMI
748
DELISTED
Foundation Medicine, Inc.
FMI
| $358K | ﹤0.01% |
19,400
+4,600
| +31% | +$83.1K |
|
|
CKH
749
DELISTED
Seacor Holdings Inc.
CKH
| $358K | ﹤0.01% |
6,474
| – | – |
|
750
Webster Financial
WBS
$12.8B
| $356K | ﹤0.01% |
+10,700
| New | +$390K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2016 Portfolio in Review
As of Q2 2016, DekaBank Deutsche Girozentrale held 1,111 positions worth $8.8B, up 4.1% from $8.45B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
DekaBank Deutsche Girozentrale deployed $350M of net new capital in Q2 2016, opening 53 new positions and adding to 455 existing holdings. Its largest new stake was S&P Global: 232,858 shares worth $24.7M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was HCA Healthcare, an estimated $24.6M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2016 buy was S&P Global: 232,858 shares worth $24.7M.
- DekaBank Deutsche Girozentrale added most to Charter Communications in Q2 2016, an estimated $77.4M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $24.6M.
- DekaBank Deutsche Girozentrale fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $37.1M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 18% of its $8.8B portfolio in Q2 2016.
- DekaBank Deutsche Girozentrale opened 53 new positions and closed 123 in Q2 2016.
- DekaBank Deutsche Girozentrale's portfolio value rose 4.1% quarter-over-quarter to $8.8B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.